These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Perspectives. CMS and Wall Street report... Med Health; 2003 Jan; 57(4):7-8. PubMed ID: 12602066 [No Abstract] [Full Text] [Related]
4. Don't pay too much for generic fills. Pass-through pricing is a good way for a payer to realize the benefit of increased prescribing of generic drugs. Cahn LJ Manag Care; 2010 Nov; 19(11):21-7. PubMed ID: 21141372 [No Abstract] [Full Text] [Related]
5. Authorized generics. Glass G Nat Rev Drug Discov; 2005 Dec; 4(12):953-4. PubMed ID: 16370080 [No Abstract] [Full Text] [Related]
12. Why these biotechs are as hot as net stocks. Wall Street's betting big on a genetic technology that burned it badly before. Monoclonal antibodies still don't cure cancer--but this time they may actually pay off. McLean B Fortune; 2000 Jan; 141(1):132-4, 135. PubMed ID: 10788044 [No Abstract] [Full Text] [Related]
13. Congress works to permit 'biosimilar' drugs very soon. Carroll J Manag Care; 2009 Apr; 18(4):7-8. PubMed ID: 19472559 [No Abstract] [Full Text] [Related]
14. A few specialty drug prices fall--all generics. Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766 [No Abstract] [Full Text] [Related]